Alibaba Group (NYSE:BABA) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Alibaba Group (NYSE:BABA) from a strong-buy rating to a buy rating in a report issued on Saturday morning.

Other equities research analysts have also recently issued reports about the company. JPMorgan Chase & Co. raised their price target on Alibaba Group from $100.00 to $108.00 and gave the company an “overweight” rating in a report on Friday, August 16th. Barclays lowered their target price on Alibaba Group from $137.00 to $130.00 and set an “overweight” rating for the company in a research note on Tuesday, November 19th. Morgan Stanley reiterated an “equal weight” rating and set a $90.00 price target on shares of Alibaba Group in a research report on Friday, August 23rd. Bank of America increased their price objective on shares of Alibaba Group from $106.00 to $124.00 and gave the stock a “buy” rating in a report on Wednesday, October 9th. Finally, Truist Financial dropped their target price on shares of Alibaba Group from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, August 16th. Two analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $114.07.

Alibaba Group Stock Down 1.6 %

Shares of NYSE BABA opened at $87.82 on Friday. The business has a fifty day moving average of $94.82 and a two-hundred day moving average of $86.34. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.37 and a current ratio of 1.37. Alibaba Group has a 52-week low of $66.63 and a 52-week high of $117.82. The stock has a market cap of $209.87 billion, a PE ratio of 17.81, a PEG ratio of 0.44 and a beta of 0.30.

Alibaba Group (NYSE:BABA) last released its quarterly earnings results on Friday, November 15th. The specialty retailer reported $15.06 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $13.19. The firm had revenue of $236.50 billion for the quarter, compared to analyst estimates of $239.45 billion. Alibaba Group had a net margin of 8.98% and a return on equity of 12.28%. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.82 earnings per share. As a group, equities research analysts expect that Alibaba Group will post 8.44 earnings per share for the current fiscal year.

Institutional Trading of Alibaba Group

Several institutional investors and hedge funds have recently made changes to their positions in BABA. First Command Advisory Services Inc. bought a new stake in Alibaba Group in the second quarter valued at about $25,000. Strategic Investment Solutions Inc. IL acquired a new position in shares of Alibaba Group in the 2nd quarter valued at $27,000. Concord Wealth Partners grew its holdings in shares of Alibaba Group by 155.0% in the 3rd quarter. Concord Wealth Partners now owns 255 shares of the specialty retailer’s stock valued at $27,000 after buying an additional 155 shares during the period. Highline Wealth Partners LLC bought a new stake in shares of Alibaba Group in the 3rd quarter valued at $36,000. Finally, Asset Dedication LLC raised its stake in Alibaba Group by 315.0% during the 2nd quarter. Asset Dedication LLC now owns 527 shares of the specialty retailer’s stock worth $38,000 after buying an additional 400 shares during the period. Institutional investors own 13.47% of the company’s stock.

About Alibaba Group

Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their users and customers in the People's Republic of China and internationally. The company operates through seven segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others.